The stock market is mixed on Tuesday, with the Dow Jones Industrial Average down 0.01%, the Nasdaq up 0.21% and the S&P up 0.51%. Tuesday’s winners include a telecommunications company who is near a deal with a larger firm and a pharmaceutical company whose drug received orphan status from the U.S. Food and Drug Administration. Meanwhile, the losers include another pharmaceutical company who discontinued a study on a lung-cancer drug and a retailer who cut its third-quarter outlook.
These are Tuesday’s market winners and losers.
Biggest Winners
Shares of MetroPCS Communications Inc. (NYSE: PCS) are up 18.19% to $13.61 on trading volume of 6.7 million shares. Bloomberg reported Tuesday that Deutsche Telekom AG is near some sort of deal with MetroPCS. Before Tuesday, the 52-week high was $12.48.
Shares of Cell Therapeutics Inc. (NASDAQ: CTIC) are up 17.49% to $2.62 on trading volume of 4 million shares. The FDA granted orphan status to its brain cancer drug, the company announced Tuesday. The 52-week high is $8.25.
Biggest Losers
Shares of ArQule Inc. (NASDAQ: ARQL) are down 55.41% to $2.23 on trading volume of 16 million shares. The company said it is discontinuing its late-stage study of a drug for lung-cancer patients since it has shown it won’t improve survival rates. Before Tuesday, the 52-week low was $4.46.
Shares of Express Inc. (NYSE: EXPR) fell 20.45% to $11.94 on trading volume of 4.8 million shares. The company cut its third-quarter profit outlook to between 16 cents and 20 cents a share, down from 27 cents to 32 cents a share. Before Tuesday, the 52-week low was $14.50.
Samuel Weigley
Follow him on Twitter: SWeigley
Credit Card Companies Are Doing Something Nuts
Credit card companies are at war. The biggest issuers are handing out free rewards and benefits to win the best customers.
It’s possible to find cards paying unlimited 1.5%, 2%, and even more today. That’s free money for qualified borrowers, and the type of thing that would be crazy to pass up. Those rewards can add up to thousands of dollars every year in free money, and include other benefits as well.
We’ve assembled some of the best credit cards for users today. Don’t miss these offers because they won’t be this good forever.
Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.